Loading chat...
AL HB419
Bill
Status
3/31/2011
Primary Sponsor
Randy Wood
Click for details
AI Summary
-
Continues the existing exemption of prescription drugs from state gross sales taxes.
-
Exempts insulin, insulin syringes, and equipment, supplies, devices, chemical reagents, and related items used by diabetics to treat diabetes or test/monitor blood or urine from state, county, and municipal sales and use taxes when purchased pursuant to a valid prescription.
-
Applies retroactively to all open tax periods and periods where preliminary or final tax assessments could be entered, but prohibits refunds for periods prior to the effective date.
-
Repeals Section 40-23-4.1 of the Code of Alabama 1975 as duplicative.
-
Becomes effective on the first day of the third month following passage and gubernatorial approval.
Legislative Description
Insulin, insulin syringes, and related items to treat diabetes, exempt from state, county, and municipal sales and use tax, prescription drug exemption from state gross sales tax continued, Sec. 40-9-30.1 added; Sec. 40-23-4.1 repealed
Taxation
Last Action
Read for the first time and referred to the House of Representatives committee on Ways and Means Education
3/31/2011